In a review of recently published scientific studies, researchers at Columbia Engineering and the University of Wisconsin-Madison identified a library of molecules that can shut down the polymerase reaction in the SARS-CoV-2 virus that causes COVID-19.
Regeneron Pharmaceuticals and Sanofi said their rheumatoid arthritis drug Kevzara failed to meet the main goals of a U.S. study testing the medicine in the most critically ill COVID-19 patients.
Researchers at the The Scripps Research Institute found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.
A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.
Gargling salt water is a time-tested way to alleviate sore-throat pain. As a nasal lavage, it can help clear stuffy sinuses associated with colds and allergies. But, is gargling salt water effective against the symptoms of COVID-19?
Gilead Sciences set the price of the only approved treatment for COVID-19, remdesivir, at $2,340 per patient for a 5-day treatment.
The United States recorded 45,242 new cases of COVID-19 on Friday – the largest single-day increase of the pandemic – according to a Reuters tally, bringing the total number of Americans who have tested positive to at least 2.48 million.
Sanofi Genzyme Executive VP Bill Sibold spoke to BioSpace about the company’s core pipeline focus, programs aimed at COVID-19, and what the future of the industry and patient care could look like in a post-COVID-19 world.
Molecular Partners aims to test a COVID-19 drug candidate on people during 2020, Chief Executive Patrick Amstutz said, as the Swiss company hopes that project will help it recover from the failure of the eye drug abicipar.
Government experts believe more than 20 million Americans could have contracted the coronavirus – 10 times more than official counts – indicating many people without symptoms have or have had the disease, senior administration officials said.